by Jennifer P | Mar 29, 2021 | OTC Drugs, U.S. Regulatory
In March 2020, provisions were added to the Federal Food, Drug, and Cosmetic Act by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which authorize FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters...
by Jennifer P | Apr 3, 2019 | Medical Devices, U.S. Regulatory
Most dialysis patients are presented with limited options for having a great quality of life. The quality diminishes further when they must consume 20-30 pills a day and have to put a harsh cap on their amount of fluid intake. Due to kidney dysfunction, they are in...
by Jennifer P | Jan 16, 2019 | Canadian Regulatory
What is a risk assessment of a chemical substance? A risk assessment is an integral part of maintaining both the health of Canadians and the environment. Risk assessments are executed by Environment and Climate Change Canada under the CEPA (Canadian Environmental...
by Jennifer P | Jan 9, 2019 | Research/Science/Technology
A constant victim of media scrutiny, blue light has recently received a lot of negative press with regards to its damaging effects to the skin. Side effects such as hyperpigmentation and oxidative stress have been found to be associated with the exposure of...
by Jennifer P | Dec 19, 2018 | Cosmetics
What is Cosmetovigilance? Cosmetovigilance can be described as the careful post-market surveillance of cosmetic products after they have been made available to consumers. More simply put it can be defined as monitoring cosmetic safety. Similarly to the concept of...
Recent Comments